Company Management

Abalos Therapeutics GmbH

Biotechnology Research Duesseldorf, Nrw, De 24 employees

Employees: 24

abalos-tx.com LinkedIn Crunchbase

Abalos Therapeutics GmbH Overview

Headquarters: Duesseldorf, Nrw, De
Phone Number: Available in AeroLeads
Website: abalos-tx.com
Industry: Biotechnology Research
Employees: 24
Funding: 35.9M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Abalos Therapeutics GmbH

Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.

Abalos Therapeutics GmbH Contact Details

People in AeroLeads: 4

Abalos Therapeutics GmbH Org Chart

Sample employees and titles

Name	Title	Contact
Sinisa Petrik, Phd	Oncolytic Virotherapy	View
Frank Hensel	Lifescience Investor and Entrepreneur	View
Klaus Binder	CEO & Founder Binder Associates Gmbh	View
Marcus Kostka	Berater Mkconsulting	View